Interview with Dr. David Yang, President, MicroConstants China
Although MicroConstants traces its history back to 1998 in San Diego, you co-founded the China operations in 2007. What’s the story behind how that came about? It all began when…
Address: Room 301,E unit, 3rd Building,Helicon Garden (Hongjialiyuan), Haidian District,Beijing 100088,China
Tel: (86-10)82050626
Formed in May 1988, the purpose of CNMA is to promote and raise the level of research, production and sales management of the Chinese OTC industry in compliance with social ethics and the relevant laws, regulations and policies.
CNMA represents the members’interests and submits policy advices to the concerned government departments on drugs’ classification, OTC research, production and sale.
CNMA also provides the members with consulting, training and information services to promote OTC technology, enhance OTC quality and ensure the consumers’ safety in using OTC products.
Another key role is to raise the knowledge and awareness about self-medication and OTC products. CNMA also organizes different activities to strengthen cooperation and contacts with international organizations, OTC associations and enterprises.
Industry Regulation and Coordination, Education
Although MicroConstants traces its history back to 1998 in San Diego, you co-founded the China operations in 2007. What’s the story behind how that came about? It all began when…
Celgene is a relative newcomer to China. What’s the story behind how the company entered the market, and how did you yourself come to manage the local operations? I officially…
We last met with you as the head of Zuellig in 2009. Obviously, a lot has changed since then; from both a sector and corporate point of view, what have…
Among Big Pharma, Sanofi has a track record of placing a lot of faith in emerging markets – with local production, a large product portfolio, and decades of experience. As…
One of the earliest innovative biotech companies in China, Zensun has developed what its founder Dr. Zhou Mingdong calls a rare made-in-China first-in-class therapeutic candidate, Neucardin®, which has been shown…
From out meeting with BPBC in 2009, we know that your slogan is to “grow up with industry.” How have you grown up since then? Firstly, I’d like to reiterate…
Chen Qiyu, chairman of Fosun Pharma, discusses how the company is helping China achieve its ‘Healthy China 2020’ goals as well as its unique business model and company culture. Fosun…
This is our first meeting in Shanghai after being based in Beijing for two months – what if any are the differences between the two cities? At the top level,…
Hu Jintao recently announced his ambitions for China to be “an innovative country” by 2020? Could you speak to the likelihood of achieving this in terms of biotechnology as you…
It seems like there’s a lot to be happy about here: Pfizer is ranked number 1 multinational R&D-based biopharmaceutical company in China, where you also have two world-class R&D centers…
You spent two decades in the US as an academic, executive, and entrepreneur, and then left to return to China and found AbMax. What’s the story behind how you came…
The Chamber recently released this year’s European Business in China Business Confidence Survey – what were some of its key takeaways? There are four main points to the Survey. The…
See our Cookie Privacy Policy Here
